Piramal Pharma Share Price (PPLPHARMA)
Check the latest share price of Piramal Pharma, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 11:31AM, 03 Jul 2025
NSE
Piramal Pharma Stock Performance
Get live Piramal Pharma share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹202.91Day's Price Range₹204.952 Week's Low
52 Week's High
₹145.2552-Week Price Range₹307.9
| Returns % | |
| 1 Month Return | + 0.25 % |
| 3 Month Return | -11.23 % |
| 1 Year Return | + 28.17 % |
| 3 Year Return | + 7.51 % |
| 5 Year Return | + 7.51 % |
| Market Stats | |
| Previous Close | ₹204.27 |
| Open | ₹202.96 |
| Volume | 11.27L |
| Upper Circuit | ₹224.69 |
| Lower Circuit | ₹183.84 |
Piramal Pharma Fundamentals & Key Indicators
Check Piramal Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹27,152.55 Cr
Return on Equity (ROE)
6.53
PE Ratio (TTM)
296.04
Return on capital employed (ROCE)
8.27
Industry PE ratio
55.73
Beta (LTM)
0.87
P/B Ratio
2.54
Dividend Yield
0.09
PEG Ratio
484.86
Quarterly Earnings Growth YOY
51.57
EPS (TTM)
0.13
Sector
Pharmaceuticals
Book Value
59.8
Technical Analysis
Bearish
View Technical Analysis
How to invest in Piramal Pharma?
Investing in Piramal Pharma is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Piramal Pharma or PPLPHARMA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Piramal Pharma or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Piramal Pharma with just a few clicks!
Piramal Pharma Stock's Interest Amongst Investors
Piramal Pharma Valuation
Track how Piramal Pharma P/E has moved over time to understand its valuation trends.
Piramal Pharma in the last 5 years
Lowest (-516.41x)
January 5, 2024
Industry (55.73x)
July 2, 2025
Today (296.04x)
July 2, 2025
Highest (2011.42x)
June 25, 2024
Today’s Price to Earnings Ratio: 296.04x
Piramal Pharma Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Piramal Pharma.
based on 10 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Piramal Pharma. Average target price of ₹267.5
Source: S&P Global Market Intelligence
Piramal Pharma Share Price Target
Get share price movements and forecasts by analysts on Piramal Pharma.
Piramal Pharma price forecast by 10 analysts
Upside of30.95%
High
₹320
Target
₹267.50
Low
₹230
Piramal Pharma target price ₹267.5, a slight upside of 30.95% compared to current price of ₹203. According to 10 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Piramal Pharma revenue growth forecast
Expected growth rate Q1, FY2027:41.36%
Forecast
Actual
Including amortisation and stock based compensations
Piramal Pharma EPS growth forecast
EPS estimate Q1, FY2027:3492.31%
Forecast
Actual
Source: S&P Global Market Intelligence
Piramal Pharma Financial Results
Get the annual and quarterly financial summary of Piramal Pharma, including revenue, profit, loss and more.
Indices Featuring Piramal Pharma Stock
Check stock indices that include Piramal Pharma.
Piramal Pharma Earnings and Dividends
View detailed summary of the earnings and dividend history of Piramal Pharma.
Piramal Pharma Ltd Earnings Results
Piramal Pharma Ltd’s net profit jumped 51.57% since last year same period to ₹153.50Cr in the Q4 2024-2025. On a quarterly growth basis, Piramal Pharma Ltd has generated 4071.2% jump in its net profits since last 3-months.
Read More about Earnings ResultsPiramal Pharma Ltd Dividends May,2024
In the quarter ending March 2024, Piramal Pharma Ltd has declared dividend of ₹0.11 - translating a dividend yield of 0.05%.
Read More about Dividends
Piramal Pharma Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Piramal Pharma.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 34.95% | 0.00 | |
| Foreign Institutions | 13.49% | 0.00 | |
| Mutual Funds | 12.73% | 0.00 | |
| Retail Investors | 18.44% | 0.00 | |
| Others | 20.4% | 0.00 |
Piramal Pharma vs Peers
Compare market cap, revenue, PE, and other key metrics of Piramal Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 27,152.55 | 1.5% | 0.58 | 17 | 8,171 | |
| BUY | 37,024.85 | 56.2% | 0.52 | 300 | 1,051 | |
| BUY | 19,080.95 | 20.37% | 0.57 | 72 | 6,702 | |
| NA | 5,206.62 | 0.35% | 0.79 | -388 | 75 | |
| BUY | 15,413.51 | 47.43% | 0.67 | 244 | 1,515 |
Piramal Pharma News & Key Events
Latest news and events in one place to help you make informed investing decisions in Piramal Pharma.
Piramal Pharma Invests $90M in U.S. Expansion - 30 Jun, 2025
Piramal Pharma Solutions is investing $90 million to expand its facilities in Michigan and Kentucky, enhancing capabilities for antibody-drug conjugate manufacturing and creating new jobs.Piramal Pharma Receives Positive Buy Rating - 25 Jun, 2025
Piramal Pharma is rated as a Buy with a target price of Rs 265, indicating a 36% upside potential. The company's CDMO business is expected to recover by FY27, supported by new manufacturing capabilities and multi-year supply orders, aiming to double revenue by FY30.Piramal Pharma Shows Strong Rebound Potential - 06 Jun, 2025
Piramal Pharma's share price is rebounding, currently near ₹208, forming a bullish flag pattern. With increasing volumes and a positive RSI trend, a sustained price above ₹210 could lead to upward movement towards ₹225 and ₹235. Traders are advised to consider buying with a stop loss at ₹198.Piramal Pharma Shares Rise on FDA Approval - 02 Jun, 2025
Piramal Pharma shares gained 1% following the USFDA's zero-observation report for its Aurora facility. The company reported a 51.5% increase in Q4 net profit.
Insights on Piramal Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 3.68 Cr → 153.5 Cr (in ₹), with an average increase of 97.6% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 11.66% to 12.73% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 2.23K Cr → 2.81K Cr (in ₹), with an average increase of 20.6% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 50.5% return, outperforming this stock by 22.3%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 34.95% of holdings in Mar 2025 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 13.68% to 13.49% in Mar 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 18.87% to 18.44% in Mar 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 months, PPLPHARMA stock has moved down by -11.2%
About Piramal Pharma
Revenue: ₹2,754.07Cr as on March 2025 (Q4 FY25)
Net Profit: ₹153.50Cr as on March 2025 (Q4 FY25)
Listing date: 19 Oct, 2022
Chairperson Name: Nandini Piramal
| Organisation | Piramal Pharma Ltd |
| Industry | Pharmaceuticals |
| CEO | Nandini Piramal |
| E-voting on shares | Click here to vote |
Mutual Funds that own Piramal Pharma
Check out the Mutual Funds with significant holdings in Piramal Pharma.
FAQs
What is Piramal Pharma share price today?
Piramal Pharma share price today stands at ₹203, Open: ₹202.96, Previous Close: ₹204.27, High: ₹204.9, Low: ₹202.91, 52 Week High: ₹307.9, 52 Week Low: ₹145.25.
What is today's traded volume of Piramal Pharma?
Today's traded volume of Piramal Pharma is 11.27L. Which means that 11.27L shares of Piramal Pharma were bought and sold on the stock market during today's trading session.
What is Piramal Pharma's market cap today?
Today's market capitalisation of Piramal Pharma is ₹27,152.55 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Piramal Pharma?
Piramal Pharma’s 52 week high is ₹307.9 and 52 week low is ₹145.25. The current share price of Piramal Pharma is ₹203, which is -34.07% down from its 52 week high and 39.76% up from its 52 week low.